Jeremy is responsible for transforming the Design capability and output of Diageo’s current brands and new products worldwide. Diageo is the world’s leading premium drinks business. He is passionate about the impact Design has on business performance and the way Design Thinking leads to breakthrough ideas wherever it is applied. Standout projects include Johnnie Walker Blue Label, Guinness Harp dispense fount (winner of the DBA Design Effectiveness Grand Prix 2020) and the Johnnie Walker Princes Street Brand Home in Edinburgh which opened in September 2021.
Prior to joining Diageo Jeremy was Head of Design for Tesco, responsible for the portfolio of 19,000 private label products and for leading the Store Formats and Design teams. His early career was as a Freelance Designer and University Lecturer.
Jeremy is a Cannes Lions and TEDx speaker. He is Chair of Trustees of the charity Soulmates Academy Foundation, Former Chair of the Design Business Association, a member of the Design Commission advising the UK government on design policy and a visiting Lecturer at Omnes Business School.
Jeremy has taken a lead role shaping the DE&I agenda on behalf of the design industry, chairing the Design Business Association DE&I Council and leading the publication of industry guidelines. https://www.dba.org.uk/site-search/?keyword=Diversity%2C+Equity+%26+Inclusion%3A He has spoken extensively on Diageo’s Inclusive Design initiatives and the positive impact when creativity is truly inclusive.
Melianthe has been working for O-I, the world’s largest glass container manufacturer, since 12 years and has a background in Marketing. She has held several positions within O-I’s commercial department covering Marketing Communication, Category Management and Innovation. Over the past couple of years she has been working with a multidisciplinary team in O-I to explore and validate direct2shape digital printing technologies for glass packaging.
In May 2018, Melianthe got appointed Global Innovation Platform Director for O-I. As part of this role she is overseeing the commercialization and global expansion of O-I : EXPRESSIONS (www.discoverexpressions.com), O-I’s platform offering personalization and customization services for brands enabled by direct2glass digital printing. Since January 2020, Melianthe expanded her role, and she is now also leading O-I’s Spirits and Wine marketing teams globally.
Growing up multilingual with Norwegian, German and Danish, Jette Cathrin Hopp is the director for acquisition and new projects and part of the executive management of Snøhetta.
Jette has extensive experience in complex both Norwegian and international projects, leading major international project developments and competitions. She regularly lectures at architectural symposia, conferences and international institutions, sharing Snøhetta´s philosophy and design ideas and she is also a jury member for several architecture competitions and prizes. Jette is also regularly invited as critic to international architecture universities. Jette is member of the Board of Trustees of the Schelling Architecture Foundation and the President of Jury for the Italian Architecture Award 2021. She is holding a teaching position at the University of Technology and Design, Wismar, Germany.
Examples of her experience are her leading role a the museum in the King Abdul Aziz Center for Knowledge and Culture, Dharhan in Saudi Arabia and as project leader for the Opera tower in Düsseldorf. She has led major international developments with focus on sustainability as Astana Expo 2017 ” Future Energy “, Kazakhstan and Lingkong Soho Shanghai, China, in Norway innovative environmental projects in Norway as Powerhouse One in Trondheim and Powerhouse Kjørbo concept phase in Sandvika which is the world first rehabilitated energy-positive building.
Dr. Marotta is assisting AmoyDx in expanding their operations in Canada. Dr. Marotta also serves as a consultant to a number of companies, and is an Adjunct Professor in the Faculty of Medicine at the University of British Columbia. Prior to working with AmoyDx, Dr. Marotta served as the Chief Scientific Officer at Augurex Life Sciences Corp. At Augurex, Dr. Marotta led the development of the company’s biomarker programs and supported the commercialization of the company’s lead asset, JOINTstat™. During his tenure, Dr. Marotta co-authored 90 scientific publications and assisted the company in receiving significant non-dilutive funding. Dr. Marotta has also held positions in Corporate Development with companies like SignalChem and Stressgen. Dr. Marotta bridges his strong scientific/clinical accumen with business expertise to bring strong value to the companies he works with. Dr. Marotta holds a Ph.D. in Experimental Medicine at the University of British Columbia.
